Abstract
The blood–brain barrier (BBB) disruption following cerebral ischemia (stroke) contributes to the development of life-threatening brain edema. Recent studies suggested that the ischemic BBB disruption is not uniform throughout the affected brain region. The aim of this study was to establish in vivo optical imaging methods to assess the size selectivity and spatial distribution of the BBB disruption after a focal cerebral ischemia. The BBB permeability was assessed in mice subjected to a 60-min middle cerebral artery occlusion and 24 h of reperfusion using in vivo time domain near-infrared optical imaging after contrast enhancement with two tracers of different molecular size, Cy5.5 (1 kDa) and Cy5.5 conjugated with bovine serum albumin (BSA) (67 kDa). Volumetric reconstruction of contrast-enhanced brain areas in vivo and ex vivo indicated that the BSA-Cy5.5-enhancement is identical to the volume of infarct determined by TTC staining, whereas the volume of enhancement with Cy5.5 was 40% greater. The volume differential between areas of BBB disruption for small and large-size molecules could be useful for determining the size of peri-infarct tissues (penumbra) that can respond to neuroprotective therapies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pardridge W.M. (2002) Drug and gene delivery to the brain: the vascular route. Neuron 36,555–8.
Wahlgren N.G., Ahmed N. (2004) Neuroprotection in cerebral ischaemia: facts and fancies-the need for new approaches. Cerebrovasc Dis. 17, 153–66.
Hofmeijer J., Veldhuis W.B., Schepers J., Nicolay K., Kappelle L.J., Bär P.R., van der Worp H.B. (2004) The time course of ischemic damage and cerebral perfusion in a rat model of space-occupying cerebral infarction. Brain Res. 1013, 74–82.
Nagaraja T.N., Karki K., Ewing J.R., Croxen R.L., Knight R.A. (2008) Identification of Variations in Blood-Brain Barrier Opening After Cerebral Ischemia by Dual Contrast-Enhanced Magnetic Resonance Imaging and T1sat Measurements. Stroke. 39, 427–432.
Wilkinson J.M., Kuok M.H., and Adamson G. (2004) Biomedical applications of optical imaging. Med Device Technol. 15, 22–24.
Licha K., Olbrich C. (2005) Optical imaging in drug discovery and diagnostic applications. Adv Drug Deliv Rev. 57,1087–108.
Ntziachristos V., Ripoll J., Wang L.V., and Weissleder R. (2005) Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol. 23,313–320.
Elson D., Requejo-Isidro J., Munro I., Reavell F., Siegel J., Suhling K., Tadrous P., Benninger R., Lever J., Neil M., Phillips D., Stamp G., French P. (2004) Time-domain fluorescence lifetime imaging applied to biological tissue. Photochem Photobiol Sci. 3,795–801.
Bloch S., Xu B., Ye Y., Liang K., Nikiforovich G.V., Achilefu S. (2006) Targeting Beta-3 integrin using a linear hexapeptide labeled with a near-infrared fluorescent molecular probe. Mol Pharm. 3,539–549.
Abulrob A., Brunette E., Slinn J., Baumann E., Stanimirovic D. (2007). In vivo time domain optical imaging of renal ischemia-reperfusion injury: discrimination based on fluorescence lifetime. Mol Imaging 6,304–14.
Abulrob A., Brunette E., Slinn J., Baumann E., Stanimirovic D. (2008). Dynamic analysis of the blood-brain barrier disruption in experimental stroke using time domain in vivo fluorescence imaging. Mol Imaging 7,248–62.
Türeyen K., Vemuganti R., Sailor K.A., and Dempsey R.J. (2004). Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques. J Neurosci. Methods 139,203–207.
Hossmann K.A. (2008) Cerebral ischemia: models, methods and outcomes. Neuropharmacology. 55, 257–70.
Pardridge W.M. (2007) Blood-brain barrier delivery. Drug Discov Today. 12, 54–61.
Colbourne F., Sutherland G., Corbett D. (1997). Postischemic hypothermia: A critical appraisal with implications for clinical treatment. Mol Neurobiol. 97, 171–201.
DeBow S., Colbourne F. (2003) Brain temperature measurement and regulation in awake and freely moving rodents. Methods. 30,167–71.
Regan H.K., Detwiler T.J., Huang J.C., Lynch J.J., Regan C.P. (2007) An improved automated method to quantitate infarct volume in triphenyltetrazolium stained rat brain sections. J Pharmacol Toxicol Methods. 56, 339–43.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Abulrob, A., Brunette, E., Slinn, J., Baumann, E., Stanimirovic, D. (2011). In Vivo Optical Imaging of Ischemic Blood–Brain Barrier Disruption. In: Turksen, K. (eds) Permeability Barrier. Methods in Molecular Biology, vol 763. Humana Press. https://doi.org/10.1007/978-1-61779-191-8_29
Download citation
DOI: https://doi.org/10.1007/978-1-61779-191-8_29
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-190-1
Online ISBN: 978-1-61779-191-8
eBook Packages: Springer Protocols